# BioCryst Pharmaceuticals (BCRX) — Overview

BCRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bcrx

## Price

Last close $7.85 on Oct 16, 2026. 52-week range $6.24 – $11.11.

## Company profile

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $940.6M |
| Revenue (quarter) | $218.3M |
| Revenue growth (year over year) | 33.61% |
| Gross profit (trailing twelve months) | $919.7M |
| Gross margin | 97.78% |
| Net income (trailing twelve months) | −$384.7M |
| Net income (quarter) | $78.4M |
| Net income growth (year over year) | 1441.69% |
| Net margin | -40.90% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$1.35 |
| Book value per share | −$1.78 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 181.44% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is BioCryst Pharmaceuticals (BCRX) profitable?

No. BioCryst Pharmaceuticals reported a net loss of $384.7M over the trailing twelve months.

### How much revenue does BioCryst Pharmaceuticals (BCRX) make?

BioCryst Pharmaceuticals generated $940.6M in revenue over the trailing twelve months, up 33.61% year over year.

### How do I buy stock in BioCryst Pharmaceuticals (BCRX)?

BCRX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).